242 related articles for article (PubMed ID: 26253468)
1. Synergistic antitumor efficacy of combined DNA vaccines targeting tumor cells and angiogenesis.
Yin X; Wang W; Zhu X; Wang Y; Wu S; Wang Z; Wang L; Du Z; Gao J; Yu J
Biochem Biophys Res Commun; 2015 Sep; 465(2):239-44. PubMed ID: 26253468
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor effect of a human papillomavirus DNA vaccine harboring E6E7 fusion gene and vascular endothelial growth factor receptor 2 gene.
Gao J; Fan L; Ma W; Xiao H
Microbiol Immunol; 2016 Sep; 60(9):626-33. PubMed ID: 27515281
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway.
Wei Y; Sun Y; Song C; Li H; Li Y; Zhang K; Gong J; Liu F; Liu Z; August JT; Jin B; Yang K
J Gene Med; 2012 May; 14(5):353-62. PubMed ID: 22438278
[TBL] [Abstract][Full Text] [Related]
4. MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model.
Zhang H; Liu C; Zhang F; Geng F; Xia Q; Lu Z; Xu P; Xie Y; Wu H; Yu B; Wu J; Yu X; Kong W
Vaccine; 2016 May; 34(24):2648-55. PubMed ID: 27113167
[TBL] [Abstract][Full Text] [Related]
5. DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model.
Zhang H; Wang Y; Liu C; Zhang L; Xia Q; Zhang Y; Wu J; Jiang C; Chen Y; Wu Y; Zha X; Yu X; Kong W
Cancer Immunol Immunother; 2012 Oct; 61(10):1857-67. PubMed ID: 22706381
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of antitumor immunity using a DNA-based replicon vaccine derived from Semliki Forest virus.
Zhang L; Wang Y; Xiao Y; Wang Y; Dong J; Gao K; Gao Y; Wang X; Zhang W; Xu Y; Yan J; Yu J
PLoS One; 2014; 9(3):e90551. PubMed ID: 24608380
[TBL] [Abstract][Full Text] [Related]
7. Enhanced synergistic anti-Lewis lung carcinoma effect of a DNA vaccine harboring a MUC1-VEGFR2 fusion gene used with GM-CSF as an adjuvant.
Ruan J; Duan Y; Li F; Wang Z
Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):71-78. PubMed ID: 27562635
[TBL] [Abstract][Full Text] [Related]
8. [Anti-tumor effects induced by the DNA vaccine coding human and mouse soluble VEGFR2].
Jin L; Zhao YW; Li ZM; Zhao CJ; Wang XF; Zhang L; Yang HS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):563-6. PubMed ID: 20848769
[TBL] [Abstract][Full Text] [Related]
9. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination.
Pan J; Heiser A; Marget M; Steinmann J; Kabelitz D
Gene Ther; 2005 May; 12(9):742-50. PubMed ID: 15729371
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary observation on antitumor effect of HPV58 composite DNA vaccine].
Wang H; Yu JY; Li L
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):523-7. PubMed ID: 24284225
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant.
Li N; Yu YZ; Yu WY; Sun ZW
Immunopharmacol Immunotoxicol; 2011 Mar; 33(1):211-9. PubMed ID: 21284488
[TBL] [Abstract][Full Text] [Related]
13. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.
Lu XL; Jiang XB; Liu RE; Zhang SM
Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067
[TBL] [Abstract][Full Text] [Related]
14. Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine.
Zhou WZ; Kaneda Y; Huang S; Morishita R; Hoon D
Gene Ther; 1999 Oct; 6(10):1768-73. PubMed ID: 10516727
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12.
Quetglas JI; Dubrot J; Bezunartea J; Sanmamed MF; Hervas-Stubbs S; Smerdou C; Melero I
Mol Ther; 2012 Sep; 20(9):1664-75. PubMed ID: 22735380
[TBL] [Abstract][Full Text] [Related]
16. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography.
Asselin-Paturel C; Lassau N; Guinebretière JM; Zhang J; Gay F; Bex F; Hallez S; Leclere J; Peronneau P; Mami-Chouaib F; Chouaib S
Gene Ther; 1999 Apr; 6(4):606-15. PubMed ID: 10476220
[TBL] [Abstract][Full Text] [Related]
17. Recombined DNA vaccines encoding calreticulin linked to HPV6bE7 enhance immune response and inhibit angiogenic activity in B16 melanoma mouse model expressing HPV 6bE7 antigen.
Zhao KJ; Cheng H; Zhu KJ; Xu Y; Chen ML; Zhang X; Song T; Ye J; Wang Q; Chen DF
Arch Dermatol Res; 2006 Jul; 298(2):64-72. PubMed ID: 16710741
[TBL] [Abstract][Full Text] [Related]
18. CpG oligodeoxynucleotides augment antitumor efficacy of folate receptor α based DNA vaccine.
Qiu Z; Xing L; Zhang X; Qiang X; Xu Y; Zhang M; Zhou Z; Zhang J; Zhang F; Wang M
Oncol Rep; 2017 Jun; 37(6):3441-3448. PubMed ID: 28498413
[TBL] [Abstract][Full Text] [Related]
19. Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models.
Fu J; Zhao B; Dong Z; Sun Y; Luan H; Shen X; Gao X; Gong F; Li S; Song H
Vaccine; 2012 Mar; 30(12):2187-96. PubMed ID: 22240343
[TBL] [Abstract][Full Text] [Related]
20. Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.
Wang YS; Wang GQ; Wen YJ; Wang L; Chen XC; Chen P; Kan B; Li J; Huang C; Lu Y; Zhou Q; Xu N; Li D; Fan LY; Yi T; Wu HB; Wei YQ
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6779-87. PubMed ID: 18006780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
